Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-01-23

FDA Approved: RISPERIDONE — Supplemental Application (Amici Pharma, Inc.)

View source ↗

Summary

FDA approved a supplemental application for risperidone from Amici Pharma, Inc., updating the drug's labeling and/or indications. This action represents a suppl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RISPERIDONE (RISPERIDONE)

Snippet

SUPPL AP for RISPERIDONE (RISPERIDONE)